九洲药业：2025年第三季度归属于上市公司股东的净利润同比增长42.30%

Core Insights - The company reported a revenue of 1,289,540,392.43 yuan for the third quarter of 2025, representing a year-on-year growth of 7.37% [1] - The net profit attributable to shareholders of the listed company was 221,821,465.85 yuan, showing a significant year-on-year increase of 42.30% [1] Financial Performance - Revenue for Q3 2025: 1,289,540,392.43 yuan, up 7.37% year-on-year [1] - Net profit for Q3 2025: 221,821,465.85 yuan, up 42.30% year-on-year [1]